Dinoprostone is used to help induce labor in pregnant women by causing the uterus to contract, and it can also help expel tissue after a miscarriage or abortion.[2] Cervidil is currently approved and in use across 5 indications[4].[1]
Cervidil is one of 42 small molecule programs targeting Induced vaginal delivery. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
105 competitors in Migraine
Cervidil
Zonegran
Triptans
Aspirin /d
Elismetrep
Flunarizine
Tizanidine Hydrochloride
Bayer Aspirin
Cymbalta
Adempas
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Regulatory
Jan 1, 1982
PROSTIN E2
NDA NDA017810
Dec 9, 1992
PREPIDIL
NDA NDA019617
Mar 30, 1995
CERVIDIL
NDA NDA020411
Sources